Cosmetic treatment company Uvence has developed a quality-controlled, 100% natural procedure, which rejuvenates skin and can fix the damage caused by dissolved fillers and botched Botox treatments.
Pioneered by leading cosmetic surgeon Dr. Olivier Amar and Profit500 business leader Reece Tomlinson, the procedure is the only one of its kind fully regulated by the Human Tissue Authority (HTA), and provides a revolutionary on-demand cosmetic treatment tool to cosmetic doctors and clinics across Britain disrupting a rapidly growing £3bn industry in the UK alone. The company, which launched its treatment in London last week, is backed by a suite of private investors hailing from the UK, France, Monaco, Greece, the Middle East and Canada. Following their early success and growing popularity, Uvence is currently preparing for a raise in September 2020.
Recent reports from Laing Buisson has suggested that the non-surgical cosmetic treatment market is currently worth around £3bn in the UK alone, with the global beauty market amounting to over £400bn. As the popularity of minimally invasive cosmetic treatments, or “tweakments”, grows to become an extension of a regular beauty regime for many, the market has experienced rapid growth in recent years. However, the lack of standardisation and regulation has been identified as a sticking point by industry experts, which will prevent cosmetic treatment companies from scaling.
The Uvence treatment Uvence creates its personalised products from a patient's own fat cells, which are extracted by an initial micro or mini liposuction. Upon extraction, the fat cells are purified to create Uvence’s patented “Super Enriched Tissue”, before being re-injected to immediately rejuvenate and dramatically improve the smoothness and elasticity of the skin.
The treatment can be carried out proactively, or can be used as a reactive solution to treat 'filler face' or poorly administered Botox treatments. Uvence can also preserve 10 injectable vials of the Super Enriched Tissue for up to 5 years, following the initial extraction, thereby providing Uvence’s patients with a long-term, natural solution to maintain a rejuvenated, youthful aesthetic.
The future of beauty is personal In addition to this never-before-seen standardised approach to cosmetic treatments, Uvence also offers a uniquely personal service to customers. In recent years, the beauty industry has begun to trend toward diversity in their products. Cosmetics, for example, have evolved from a one-sized fits all approach with very limited options, to the current day in which beauty products are developed for people of all backgrounds, skin tones and skin types.
As this trend continues to develop, the future of the beauty and cosmetic treatment industry will become more and more personal. Uvence is peerless in their provision of treatments which are completely unique to each individual, by providing a treatment which uses a patient’s own purified tissue to regenerate their skin.
Dr. Olivier Amar – leading cosmetic surgeon and Chief Medical Officer of Uvence
Dr. Olivier Amar is one of Europe’s leading aesthetic consultants, with over 15 years of experience in cosmetic, plastic and reconstructive surgery. As one of the leading Olivier has become the pioneering surgeon in fat-transfer in the UK, and has been instrumental in the development of the revolutionary Uvence treatment.
“This really is the future of cosmetic skin treatments, it is hugely exciting to see the next step in standardisation and quality for this kind of treatment. The Uvence offering allows access to regenerative and personalised treatments and is the biggest advance in the field for nearly 15 years. In terms of accessibility and convenience this has never been seen before, the cryopreservation capability allows plastic and cosmetic surgeons alike to provide this treatment on a consistent basis to their patients without the need for further liposuction or tissue extraction.”
Reece Tomlinson, Profit500 business leader and CEO of Uvence, commented on the launch:
"The aesthetic medical space is primed for innovation due to the usage of primarily legacy technologies. We viewed the utilisation of the body’s own capacity to repair itself as being a prime opportunity to provide the next generation of treatment options for patients. This becomes more relevant as the regenerative capability of the body is increasingly understood and the technological abilities to utilise these abilities become feasible.
While we cannot stop the ageing process, we can slow it down, and that is exactly what a Uvence treatment allows us to do. This kind of treatment ‘resets the clock’ on ageing without the permanence of surgery, or potential toxicity of other cosmetic treatments. With the cosmetic surgery market expected to be worth $43.9bn by 2025, we believe that Uvence's process, technology, and storage facilities offer a genuinely game-changing alternative to invasive cosmetic treatments."
Dr. Maryam Zamani, leading oculoplastic surgeon, discusses why she is offering Uvence treatments: "I think this is a perfect addition to the arsenal of treatments I provide. Uvence is an innovative way to harvest small amounts of fat in a short procedure to then prepare into super enriched tissue to help improve quality of the skin. It can be used in combination with injectables, energy based treatments and surgery to bolster collagen production and a more youthful preservation. The beauty of this treatment is that you can harvest enough fat to produce injectable super enriched tissue to use for up to five years.